Cargando…

An update on antibody–drug conjugates in urothelial carcinoma: state of the art strategies and what comes next

In recent years, considerable progress has been made in increasing the knowledge of tumour biology and drug resistance mechanisms in urothelial cancer. Therapeutic strategies have significantly advanced with the introduction of novel approaches such as immune checkpoint inhibitors and Fibroblast Gro...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Angelo, Alberto, Chapman, Robert, Sirico, Marianna, Sobhani, Navid, Catalano, Martina, Mini, Enrico, Roviello, Giandomenico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402760/
https://www.ncbi.nlm.nih.gov/pubmed/35953604
http://dx.doi.org/10.1007/s00280-022-04459-7